The gain-of-function (GOF) mechanism of the disease highlights the toxicity of aggregating proteins like amyloid-beta in AD, α-synuclein in PD, LBD, or MSA, and tau protein in PSP. This evidence concerns the gene SNCA and Parkinson disease.